Effect of the probiotic saccharomyces boulardii on cholesterol and lipoprotein particles in hypercholesterolemic adults: A single-arm, open-label pilot study

Journal of Alternative and Complementary Medicine

Volumn 21, Issue 5, 2015, Pages 288-293

  Ryan, Jennifer Joan ^a   Hanes, Douglas Allen ^a   Schafer, Morgan Beth ^a   Mikolai, Jeremy ^a   Zwickey, Heather ^a  

^a National College of Natural Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B100; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; INSULIN; LIPOPROTEIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROBIOTIC AGENT; REMNANT LIPOPROTEIN PARTICLE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN PARTICLE;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DRUG EFFICACY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LIPOPROTEIN BLOOD LEVEL; MALE; METHODOLOGY; OPEN STUDY; OUTCOME ASSESSMENT; PILOT STUDY; PRIORITY JOURNAL; SACCHAROMYCES BOULARDII; SINGLE ARM STUDY; TREATMENT DURATION; AGED; BLOOD; BODY MASS; DIET THERAPY; LIFESTYLE; MIDDLE AGED; SACCHAROMYCES; YOUNG ADULT;

ADULT; AGED; BIOMARKERS; BODY MASS INDEX; CHOLESTEROL; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; LIFE STYLE; LIPOPROTEINS; MALE; MIDDLE AGED; PILOT PROJECTS; PROBIOTICS; SACCHAROMYCES; YOUNG ADULT;

EID: 84929148334     PISSN: 10755535     EISSN: 15577708     Source Type: Journal    
DOI: 10.1089/acm.2014.0063     Document Type: Article

References (25)

1. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380: 2095-2128
2. Stamler J, Wentworth D, Neaton JD. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded?. Findings in 356, 222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT) JAMA. 1986; 256: 2823-2828
3. Avenue G. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002; 106: 3143-3421
4. Jones ML, Martoni CJ, Prakash S. Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: A randomized controlled trial. Eur J Clin Nutr. 2012; 66: 1234-1241
5. Hlivak P, Odraska J, Ferencik M, et al. One-year application of probiotic strain Enterococcus faecium M-74 decreases serum cholesterol levels. Bratisl Lek Listy. 2005; 106: 67-72
6. Schaafsma G, Meuling WJ, van Dokkum W, et al. Effects of a milk product, fermented by Lactobacillus acidophilus and with fructo-oligosaccharides added, on blood lipids in male volunteers. Eur J Clin Nutr. 1998; 52: 436-440
7. Kiessling G, Schneider J, Jahreis G. Long-Term consumption of fermented dairy products over 6 months increases HDL cholesterol. Eur J Clin Nutr. 2002; 56: 843-849
8. Kumar M, Nagpal R, Kumar R, et al. Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases. Exp Diabetes Res. 2012; 2012: 902917
9. Lye H-S, Rahmat-Ali GR, Liong M-T. Mechanisms of cholesterol removal by lactobacilli under conditions that mimic the human gastrointestinal tract. Int Dairy J. 2010; 20: 169-175
10. Kimoto H, Ohmomo S, Okamoto T. Cholesterol removal from media by lactococci. J Dairy Sci. 2002; 85: 3182-3188
11. Usman Ha. Bile tolerance, taurocholate deconjugation, and binding of cholesterol by Lactobacillus gasseri strains. J Dairy Sci. 1999; 82: 243-248
12. Psomas EI, Fletouris DJ, Litopoulou-Tzanetaki E, Tzanetakis N. Assimilation of cholesterol by yeast strains isolated from infant feces and Feta cheese. J Dairy Sci. 2003; 86: 3416-3422
13. McFarland LV. Systematic review and meta-Analysis of Saccharomyces boulardii in adult patients. World J Gastroenterol. 2010; 16: 2202
14. Sindhu SC, Khetarpaul N. Effect of feeding probiotic fermented indigenous food mixture on serum cholesterol levels in mice. Nutr Res. 2003; 23: 1071-1080
15. Cromwell WC, Otvos JD, Keyes MJ, et al. LDL Particle number and risk of future cardiovascular disease in the Framingham Offspring Study-Implications for LDL management. J Clin Lipidol. 2007; 1: 583-592
16. Rosenson RS, Underberg Ja. Systematic review: Evaluating the effect of lipid-lowering therapy on lipoprotein and lipid values. Cardiovasc Drugs Ther. 2013; 27: 465-479
17. Otvos JD, Mora S, Shalaurova I, et al. Clinical implications of discordance between low-density lipoprotein cholesterol and particle number. J Clin Lipidol. 2011; 5: 105-113
18. Troup JM, inventor; SpectraCell Laboratories, Inc., assignee. Method for analyzing blood for lipoprotein components. US Patent 7, 856, 323 B2. December 21, 2010
19. Havel RJ. Remnant lipoproteins as therapeutic targets. Curr Opin Lipidol. 2000; 11: 615-620
20. Karpe F, Boquist S, Tang R, et al. Remnant lipoproteins are related to intima-media thickness of the carotid artery independently of LDL cholesterol and plasma triglycerides. J Lipid Res. 2001; 42: 17-21
21. Takeichi S, Yukawa N, Nakajima Y, et al. Association of plasma triglyceride-rich lipoprotein remnants with coronary atherosclerosis in cases of sudden cardiac death. Atherosclerosis. 1999; 142: 309-315
22. Kugiyama K, Doi H, Motoyama T, et al. Association of remnant lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries. Circulation. 1998; 97: 2519-2526
23. Nakamura T, Obata J, Hirano M, et al. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDLcholesterol goals. Atherosclerosis. 2011; 218: 163-167
24. de Roos N, Katan M. Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis: A review of papers published between 1988 and 1998. Am J Clin Nutr. 2000; 71: 405-411
25. Ooi L, Liong M. Cholesterol-lowering effects of probiotics and prebiotics: A review of in vivo and in vitro findings. Int J Mol Sci. 2010; 11: 2499-2522